Ruby-O Clinical Study

Ruby-O Clinical Study

Unlike conventional Omega-3s, Ruby-O® powered by BPL-O3™ technology leverages phospholipid bonding to form nanoemulsions during digestion, enhancing absorption and efficient transport into target tissues. Clinical data confirms its ability to deliver triglyceride reduction and Omega-3 Index improvements at lower daily doses, while its bonded phospholipid structure makes Ruby-O® a versatile platform adaptable to cardiovascular, cognitive, women’s health, and sports nutrition applications.

Download whitepaper

At NaturMega, we respect your privacy. We’ll use your personal information only to manage your account and provide the products and services you request.

By checking this box, you agree that NaturMega may store and process your data and send you relevant information and offers via email. You can unsubscribe at any time and request access to, correction of, or deletion of your personal data whenever you wish.